TY - JOUR
T1 - Role of right upper mediastinal lymph node metastasis in patients with esophageal squamous cell carcinoma after tri-incisional esophagectomies
AU - Hsu, Po Kuei
AU - Huang, Chien Sheng
AU - Hsieh, Chih Cheng
AU - Wu, Yu Chung
AU - Hsu, Wen Hu
N1 - Publisher Copyright:
© 2014 Elsevier Inc. All rights reserved.
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Background Whereas standard (infracarinal) mediastinal lymphadenectomy refers to the clearance of lymph nodes in the middle and lower posterior mediastinum, extension along right side of trachea and upper mediastinum is termed extended lymphadenectomy. The benefit of an extended versus standard lymphadenectomy in esophageal cancer is unclear.Methods The clinicopathologic data of 391 patients undergoing tri-incisional esophagectomy (McKeown type) for squamous cell carcinoma between 1995 and 2007 were analyzed retrospectively. There were 136 and 255 patients in the infracarinal and extended mediastinal lymphadenectomy groups, respectively. The outcome of these two groups and the clinical importance of right upper mediastinum lymph node metastases (LNM) were investigated.Results Both groups were comparable in clinicopathologic characteristics except tumor length (infracarinal vs extended group, 4.6 vs 5.2 cm, P =.023) and lymph node status. The 5-year overall survival rates were 29.7% and 27.3%, in the infracarinal and extended groups, respectively (P =.065). In the extended group, the factors correlated to right upper mediastinal LNM included neck LNM (hazard ratio [HR] 2.621, P =.029), abdominal LNM (HR 2.218, P =.016), and tumor locating in the upper/middle third of esophagus (HR 2.781, P =.014). The independent prognostic factors for overall survival included right upper mediastinal LNM (HR 1.964, P <.001), lower mediastinal LNM (HR 1.391, P =.039), and abdominal LNM (HR 1.538, P =.006).Conclusion The procedure of right upper mediastinum lymphadenectomy is not associated with better survival in patients with esophageal squamous cell carcinoma patients; the presence of upper mediastinum LNM predicted poor prognosis.
AB - Background Whereas standard (infracarinal) mediastinal lymphadenectomy refers to the clearance of lymph nodes in the middle and lower posterior mediastinum, extension along right side of trachea and upper mediastinum is termed extended lymphadenectomy. The benefit of an extended versus standard lymphadenectomy in esophageal cancer is unclear.Methods The clinicopathologic data of 391 patients undergoing tri-incisional esophagectomy (McKeown type) for squamous cell carcinoma between 1995 and 2007 were analyzed retrospectively. There were 136 and 255 patients in the infracarinal and extended mediastinal lymphadenectomy groups, respectively. The outcome of these two groups and the clinical importance of right upper mediastinum lymph node metastases (LNM) were investigated.Results Both groups were comparable in clinicopathologic characteristics except tumor length (infracarinal vs extended group, 4.6 vs 5.2 cm, P =.023) and lymph node status. The 5-year overall survival rates were 29.7% and 27.3%, in the infracarinal and extended groups, respectively (P =.065). In the extended group, the factors correlated to right upper mediastinal LNM included neck LNM (hazard ratio [HR] 2.621, P =.029), abdominal LNM (HR 2.218, P =.016), and tumor locating in the upper/middle third of esophagus (HR 2.781, P =.014). The independent prognostic factors for overall survival included right upper mediastinal LNM (HR 1.964, P <.001), lower mediastinal LNM (HR 1.391, P =.039), and abdominal LNM (HR 1.538, P =.006).Conclusion The procedure of right upper mediastinum lymphadenectomy is not associated with better survival in patients with esophageal squamous cell carcinoma patients; the presence of upper mediastinum LNM predicted poor prognosis.
UR - http://www.scopus.com/inward/record.url?scp=84908300484&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908300484&partnerID=8YFLogxK
U2 - 10.1016/j.surg.2014.05.007
DO - 10.1016/j.surg.2014.05.007
M3 - Article
C2 - 24953277
AN - SCOPUS:84908300484
SN - 0039-6060
VL - 156
SP - 1269
EP - 1277
JO - Surgery (United States)
JF - Surgery (United States)
IS - 5
ER -